Rengalin tabs #20

Rengalin user manual

To buy Rengalin just add it to your shopping cart

The preparation Rengalin is available in the form of a tablet for resorption. He represents the clinical and pharmacological group of medicines antitussive drugs with anti-bronchoconstrictive action and is used to treat various pathologies of the lungs and bronchi accompanied by a cough.

Composition and form of release

Tablets for resorption Rengalin have a round, flat-cylindrical shape, white or almost white. On the one hand, there is a dividing risk for the possibility of breaking the tablets in half. The composition of the drug includes 3 main operating components, which include:
    Antibodies to histamine.
    Antibodies to bradykinin.
    Antibodies to morphine.
Their content in one tablet is 0.006 g. Also, the formulation includes auxiliary substances, which include sodium cyclamate, magnesium stearate, anhydrous citric acid, isomalt, sodium saccharin. Tablets are packaged in a contour squamous package of 10 pieces. The cardboard pack contains 1, 2 or 5 contour packs and instructions for the use of the preparation.

Pharmacodynamics and pharmacokinetics

The pharmacological action of Rengalin tablets is due to the main active ingredients that it contains, which are represented by antibodies. They modify the regulatory effects of endogenous (intrinsic) biologically active compounds on histamine, bradykinin and opiate receptors, localized primarily in the bronchi and lungs. With the combined effect of the antibodies of the drug on the corresponding receptors, an antitussive therapeutic effect develops. Also, Rengalin tablets reduce the severity of inflammation, edema, allergic reactions, pain in the tissues of the lower respiratory tract, and also help relax the smooth muscles of the bronchial walls with the expansion of their lumen (dilatation, underlying the anti-bronchoconstrictive action) and improve air flow. The drug has a central effect on the cough center of the medulla oblongata. Unlike narcotic drugs with a central antitussive effect, it does not inhibit breathing, does not cause addiction and drug dependence.
The sensitivity of modern laboratory research methods does not make it possible to reliably study the pharmacokinetics (suction rate, distribution, metabolism and excretion of the active ingredients of the drug) of the components of Rengalin tablets.

Indications for use

A medical indication for the use of Rengalin resorption tablets is a complex pathogenetic therapy of chronic respiratory pathology, which is accompanied by cough and bronchospasm (bronchospasm narrowing), in particular chronic obstructive bronchitis, atopic bronchitis, bronchial asthma. Also, the drug is used to reduce cough in acute respiratory viral pathology, inflammatory pathology of the upper respiratory tract (acute pharyngitis, laryngitis, tracheitis), inflammatory and allergic diseases of the respiratory system.

Contraindications for Rengalin

Absolute contraindication to the use of tablets for resorption Rengalin is an individual intolerance to any of the components of the drug. It is not recommended to use it for children under 3 years old, since there is no reliable data on safety at this age for today.

Dosing and Administration

Rengalin tablets are intended for resorption. One tablet is placed in the oral cavity and kept until completely dissolved. The average therapeutic dose is 1-2 tablets 3 times a day. With a pronounced cough accompanied by bronchospasm, the frequency of taking tablets for resorption of Rengalin can be increased up to 4-6 times a day. As the condition improves and the intensity of cough decreases, they pass to the average therapeutic dose. The duration of the drug is determined by the disappearance of symptoms of inflammatory pathology of the respiratory system.

Side effects of Rengalin

In general, the tablets for resorption of Rengalin are transferred well. Sometimes, against the background of their reception, it is possible to develop reactions of intolerance, which are accompanied by nausea, allergic manifestations in the form of a rash on the skin, its itching, urticaria (characteristic rash and swelling of skin areas that resemble a nettle burn).

special instructions

Before you start taking Rengalin resorption tablets, you should carefully read the instructions for the drug, make sure there are no contraindications, and pay attention to a few special instructions, which include:
    There are no data on the safety of the drug on the developing fetal organism, therefore its use for pregnant and lactating women is not recommended, with the exception of strict medical indications, when the expected benefit for the mother exceeds the potential risks to the fetus. In these cases, Rengalin tablets are prescribed only by a doctor.
    Cases of incompatibility of the active components of the drug with drugs of other pharmacological groups have not been recorded.
    The drug has no effect on the functional state of the brain structures, the speed of psychomotor reactions and the ability to concentrate.
In the pharmacy network, resorption tablets are dispensed without a prescription. If you have any doubts about the use of the drug, you should consult your doctor for advice.

Overdose

In case of accidental significant excess of the recommended therapeutic dosage of tablets for resorption of Rengalin, dyspeptic phenomena in the form of nausea and vomiting may develop. In this case, the drug should be discontinued and seek medical attention.

Terms and conditions of storage

The shelf life of the Rengalin resorption tablets is 3 years. The drug should be stored only in its original packaging, in a dark, dry place inaccessible to children at an air temperature of no more than + 25 ° C.

Terms of sell

To buy Rengalin tablets you don't need a prescription.